Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer

FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer

US Patent 10434075 · Granted Oct 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2025
Next generation FKBP52 targeting drugs for the treatment of prostate and breast 2024
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2020
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prost2019
Treatment of breast cancer2018
Intravenous formulation and LC/MS/MS analysis method for GMC12018
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen2017
Treatment of breast cancer2016
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen2016
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen2014
MiRNAs dysregulated in triple-negative breast cancer2013
Progesterone receptor-regulated gene expression and methods related thereto2004